T-cell immunotherapy holds promise for the treatment of cancer, infection, and autoimmune diseases. Nevertheless, T-cell therapy is limited by low cell expansion efficiency ex vivo and functional deficits. Here we describe two 3D bioprinting systems made by different biomaterials that mimic the in vivo formation of natural lymph vessels and lymph nodes which modulate T-cell with distinct fates and functions. We observe that coaxial alginate fibers promote T-cell expansion, less exhausted and enable CD4+ T-cell differentiation into central memory-like phenotype (Tcm), CD8+ T-cells differentiation into effector memory subsets (Tem), while alginate-gelatin scaffolds bring T-cells into a relatively resting state. Both of the two bioprinting methods are strikingly different from a standard suspension system. The former bioprinting method yields a new system for T-cell therapy and the latter method can be useful for making an immune-chip to elucidate links between immune response and disease.
Keyphrases
- cell therapy
- tissue engineering
- resting state
- functional connectivity
- immune response
- stem cells
- lymph node
- mesenchymal stem cells
- working memory
- endothelial cells
- traumatic brain injury
- dendritic cells
- papillary thyroid
- high throughput
- machine learning
- squamous cell carcinoma
- combination therapy
- regulatory t cells
- young adults
- early stage
- lymph node metastasis
- pluripotent stem cells
- sentinel lymph node
- artificial intelligence
- bone marrow
- replacement therapy
- type iii